uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
Go back to uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease| UNIQURE (NASDAQ: QURE) | Delayed: 48.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.37 | 52 Week High | $22.79 | |||
| Open | $48.37 | 52 Week Low | $6.63 | |||
| Day High | $48.37 | P/E | N/A | |||
| Day Low | $48.37 | EPS | $0.00 | |||
| Volume | 778 | |||||

